Alterity Therapeutics Limited (ATHE)

Alterity Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 4, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Market Cap	79	62	16	11	24	45
Market Cap Growth	160.07%	293.56%	39.27%	-53.59%	-45.84%	-99.98%
Enterprise Value	43.08	40.48	7.41	0.91	0.49	24.11
Last Close Price	4.52	4.09	1.81	2.79	6.10	13.00
PE Ratio	-	-5.46	-0.87	-1.23	-2.78	-3.21
PS Ratio	17.74	12.38	5.89	4.35	6.92	13.43
PB Ratio	2.17	2.23	1.72	0.75	1.00	1.98
P/TBV Ratio	-	1.03	0.80	0.50	0.69	1.21
P/FCF Ratio	-	-8.26	-1.88	-0.85	-2.85	-3.47
P/OCF Ratio	-	-8.26	-1.88	-0.85	-2.87	-3.48
EV/Sales Ratio	9.73	8.05	2.76	0.35	0.14	7.17
EV/EBITDA Ratio	-	-5.00	-0.57	-0.09	-0.05	-2.13
EV/EBIT Ratio	-	-4.94	-0.57	-0.09	-0.05	-2.12
EV/FCF Ratio	-	-5.37	-0.88	-0.07	-0.06	-1.85
Debt / Equity Ratio	-	0.00	0.00	0.00	0.00	0.00
Debt / EBITDA Ratio	-	-0.01	-0.01	-0.01	-0.01	0.00
Debt / FCF Ratio	-	-0.01	-0.01	-0.01	-0.01	0.00
Net Debt / Equity Ratio	-	-0.78	-0.90	-0.68	-0.98	-0.92
Net Debt / EBITDA Ratio	-	2.68	0.64	1.07	2.25	1.86
Net Debt / FCF Ratio	-	2.88	0.99	0.78	2.79	1.62
Asset Turnover	-	0.23	0.17	0.11	0.14	0.21
Quick Ratio	-	10.49	3.10	5.58	6.79	10.56
Current Ratio	-	12.98	3.54	6.17	7.07	10.92
Return on Equity (ROE)	-	-42.75%	-103.97%	-46.66%	-38.54%	-81.39%
Return on Assets (ROA)	-	-37.97%	-84.05%	-42.40%	-41.14%	-69.73%
Return on Invested Capital (ROIC)	-	-228.35%	-448.04%	-358.72%	-948.65%	-6599.81%
Return on Capital Employed (ROCE)	-	-44.23%	-106.60%	-50.17%	-46.93%	-80.42%
Earnings Yield	-12.39%	-18.33%	-115.13%	-81.62%	-35.97%	-31.14%
FCF Yield	-12.55%	-12.10%	-53.23%	-117.63%	-35.04%	-28.79%
Buyback Yield / Dilution	-74.72%	-75.31%	-50.29%	-0.91%	-41.79%	-89.62%
Total Shareholder Return	-74.72%	-75.31%	-50.29%	-0.91%	-41.79%	-89.62%

Updated Mar 31, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q